Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and speed of new drug approvals.
Senate Republicans eye crackdown on Medicare Advantage upcoding as a way to finance tax cuts in Trump's "Big Beautiful Bill."
Kennedy’s personal experience with unproven stem cells seems to make him inclined to reduce FDA oversight drastically.
Our research project sought to ask questions about the value of America’s universities to society. The results were stunning.
The companies are developing drugs for a kidney condition called IgA nephropathy, aiming to slow or halt the deterioration of kidney function.
Omada Health, which has been a digital health company for 14 years supporting patients with chronic diseases, has yet to generate profits.
A longtime medical forensic expert worries that the recent approval of at-home cervical cancer screening tests could have unexpected consequences.
